Skip to Content

Eptifibatide

In the US, Eptifibatide (eptifibatide systemic) is a member of the drug class glycoprotein platelet inhibitors and is used to treat Acute Coronary Syndrome, Angina, Heart Attack and Percutaneous Coronary Intervention.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AC16

CAS registry number (Chemical Abstracts Service)

0148031-34-9

Chemical Formula

C35-H49-N11-O9-S2

Molecular Weight

834

Therapeutic Category

Antiplatelet agent: Glycoprotein IIb/IIIa-receptor antagonist

Chemical Name

Cyclo(S-S)-mercaptopropionyl-(L) homoarginyl-glycyl-(L) aspartyl-(L) tryptophanyl-(L) prolyl-(L) cysteinamide

Foreign Names

  • Eptifibatidum (Latin)
  • Eptifibatid (German)
  • Eptifibatide (French)
  • Eptifibatida (Spanish)

Generic Names

  • Eptifibatide (OS: DCF, BAN)
  • C 6822 (IS)
  • Intrifiban (IS)
  • SB 1 (IS)
  • SCH 60936 (IS)
  • Eptifibatide acetate (OS)
  • 031E349 (IS)
  • CHEBI:291902 ACETATE (IS)
  • SCHEMBL1890434 (IS)

Brand Names

  • Clotide
    Biocon, India
  • Coromax
    USV, India
  • Eptifab
    AHPL, India
  • Eptifibatid Accord
    Accord Healthcare, Denmark
  • Eptifibatida Strides
    Strides, Spain
  • Eptifibatide
    Akorn Animal Health, United States; Amneal Pharmaceuticals, United States; Aurobindo Pharma USA, United States; Teva, United States
  • Eptifibatide Accord
    Accord, Lithuania; Accord, Portugal; Accord Healthcare, Belgium; Accord Healthcare, Estonia; Accord Healthcare, France; Accord Healthcare, United Kingdom; Accord Healthcare, Norway; Accord Healthcare, Romania; Accord Healthcare, Sweden; Evopharm, Slovakia
  • Eptifibatide Accord 0.75 mg/ml
    Accord Healthcare, Austria
  • Eptifibatide ADOH
    ADOH, Netherlands
  • Eptifibatide Mylan
    Mylan dura, Lithuania
  • Eptifibatide Mylan 0.75mg/ml
    Agila Specialties, Bulgaria
  • Eptifibatide Mylan 2mg/ml
    Agila Specialties, Bulgaria
  • Eptifibatide Strides
    Strides Arcolab, Italy; Strides Arcolab, Poland
  • Eptifibatide Teva
    Teva, Israel
  • Integrilin
    Glaxo Group, Cyprus; Glaxo Group, Lithuania; Glaxo Group, Poland; Glaxo Group, Romania; Glaxo Group Limited, Iceland; Glaxo Operations UK, Serbia; GlaxoGroup, Netherlands; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Latvia; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden; GlaxoSmithKline A.B.E.E., Greece; GlaxoSmithKline Laboratoire Pharmaceutique, France; GlaxoSmithKline UK, United Kingdom; GSK, Belgium; GSK, Czech Republic; GSK, Slovakia; Lex ano, Lithuania; Merck Canada, Canada; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Hong Kong; MSD, Thailand; Schering, Pakistan; Schering, United States; Schering-Plough, Indonesia; Schering-Plough, Kuwait; Schering-Plough, Taiwan; Schering-Plough, South Africa; Scherring, Egypt; Merck Sharp & Dohme Pharma Singapore, Singapore
  • Integrilin 0.75 mg/ml
    Glaxo Group, Hungary
  • Integrilin 0.75mg/ml
    Glaxo Group, Austria; GlaxoSmithKline, Luxembourg; Schering-Plough Lab., Israel
  • Integrilin 2 mg/ml
    Glaxo Group, Hungary
  • Integrilin 20mg/10ml
    GlaxoSmithKline, Switzerland
  • Integrilin 2mg/ml
    Glaxo Group, Austria; GlaxoSmithKline, Luxembourg; Schering-Plough Lab., Israel
  • Integrilin 75mg/100ml
    GlaxoSmithKline, Switzerland
  • Unigrilin
    United Biotech, India
  • Integrilin
    Merck Sharp & Dohme, New Zealand

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.